NDC 60505-6214
ICATIBANT
Icatibant Acetate
ICATIBANT is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Apotex Corp.. The primary component is Icatibant Acetate.
Product ID | 60505-6214_626483ed-d5c0-49d9-b8f8-3fd1920118ca |
NDC | 60505-6214 |
Product Type | Human Prescription Drug |
Proprietary Name | ICATIBANT |
Generic Name | Icatibant Acetate |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2020-12-18 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA212081 |
Labeler Name | Apotex Corp. |
Substance Name | ICATIBANT ACETATE |
Active Ingredient Strength | 30 mg/3mL |
Pharm Classes | Bradykinin B2 Receptor Antagonist [EPC],Bradykinin B2 Receptor Antagonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |